Reduced macrophage selenoprotein expression alters oxidized lipid metabolite biosynthesis from arachidonic and linoleic acid

Journal of Nutritional Biochemistry

Volumn 25, Issue 6, 2014, Pages 647-654

  Mattmiller, Sarah A ^a   Carlson, Bradley A ^b   Gandy, Jeff C ^a   Sordillo, Lorraine M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Eicosanoids; Macrophage; Oxylipids; Selenium; Selenoproteins

Indexed keywords

ARACHIDONIC ACID; LINOLEIC ACID; LIPOXIN A; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; SELENOPROTEIN; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; 9-OXO-10,12-OCTADECADIENOIC ACID; AUTACOID; LINOLENIC ACID; LIPID PEROXIDE; LIPOXIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; LIPOGENESIS; LIQUID CHROMATOGRAPHY; MACROPHAGE MIGRATION; MASS SPECTROMETRY; METABOLITE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CROSS BREEDING; DOWN REGULATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; TRANSFORMED CELL LINE; TRANSGENIC MOUSE;

MUS;

ANIMALS; ARACHIDONIC ACID; CELL LINE, TRANSFORMED; CROSSES, GENETIC; DOWN-REGULATION; INFLAMMATION MEDIATORS; LINOLEIC ACID; LINOLENIC ACIDS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOXINS; LIPOXYGENASES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SELENOPROTEINS;

EID: 84899967077     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.02.005     Document Type: Article

References (41)

1. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6(12):1191-1197.
2. Sordillo L.M., Aitken S.L. Impact of oxidative stress on the health and immune function of dairy cattle. Vet Immunol Immunopathol 2009, 128(1-3):104-109.
3. Merched A.J., Ko K., Gotlinger K.H., Serhan C.N., Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008, 22(10):3595-3606.
4. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5(12):953-964.
5. Schmitz G., Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008, 47(2):147-155.
6. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009, 47(5):469-484.
7. Bolick D.T., Orr A.W., Whetzel A., et al. 12/15-Lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-κB. Arterioscler Thromb Vasc Biol 2005, 25(11):2301-2307.
8. Fogh K., Stender Hansen E., Herlin T., et al. 15-Hydroxy-eicosatetraenoic acid (15-Hete) inhibits carragheenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4). Prostaglandins 1989, 37(2):213-228.
9. Yuan H., Li M.-Y., Ma L.T., et al. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer. Thorax 2010, 65(4):321-326.
10. Bellinger F.P., Raman A.V., Reeves M.A., Berry M.J. Regulation and function of selenoproteins in human disease. Biochem J 2009, 422(1):11-22.
11. Nam K.N., Koketsu M., Lee E.H. 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-κB inhibition. Eur J Pharmacol 2008, 589(1-3):53-57.
12. Zamamiri-Davis F., Lu Y., Thompson J.T., et al. Nuclear factor-κB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 2002, 32(9):890-897.
13. Weaver J.A., Maddox J.F., Cao Y.Z., Mullarky I.K., Sordillo L.M. Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells. Free Radic Biol Med 2001, 30(3):299-308.
14. Sordillo L.M., Streicher K.L., Mullarky I.K., Gandy J.C., Trigona W.L., Corl C.M. Selenium inhibits 15-hydroperoxyoctadecadienoic acid-induced intracellular adhesion molecule expression in aortic endothelial cells. Free Radic Biol Med 2008, 44:34-43.
15. Funk C.D., Boubez W., Powell W.S. Effects of selenium-deficient diets on the production of prostaglandins and other oxygenated metabolites of arachidonic acid and linoleic acid by rat and rabbit aortae. Biochim Biophys Acta 1987, 921(2):213-220.
16. Saito Y., Yoshida Y., Niki E. Cholesterol is more susceptible to oxidation than linoleates in cultured cells under oxidative stress induced by selenium deficiency and free radicals. FEBS Lett 2007, 581(22):4349-4354.
17. Hatfield D.L., Carlson B.A., Xu X., Mix H., Gladyshev V.N., Kivie M. Selenocysteine incorporation machinery and the role of selenoproteins in development and health. Progress in Nucleic Acid Research and Molecular Biology 2006, Volume 81:97-142. Academic Press.
18. McKenzie R.C., S.Rafferty T., Beckett G.J. Selenium: an essential element for immune function. Immunol Today 1998, 19(8):342-345.
19. Banning A., Florian S., Deubel S., et al. GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Antioxid Redox Signal 2008, 10(9):1491-1500.
20. Heirman I., Ginneberge D., Brigelius-Flohé R., et al. Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy. Free Radic Biol Med 2006, 40(2):285-294.
21. Vunta H., Davis F., Palempalli U.D., et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-12,14-prostaglandin J2 in macrophages. J Biol Chem 2007, 282(25):17964-17973.
22. Gandhi U.H., Kaushal N., Ravindra K.C., et al. Selenoprotein-dependent upregulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR)gamma. J Biol Chem 2011, 286(31):27471-27482.
23. Gairola C., Tai H.-H. Selective inhibition of leukotriene B4 biosynthesis in rat pulmonary alveolar macrophages by dietary selenium deficiency. Biochem Biophys Res Commun 1985, 132(1):397-403.
24. Wittwer J., Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007, 77(2):67-77.
25. Carlson B., Yoo M.-H., Sano Y., et al. Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression. BMC Immunol 2009, 10(1):57.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδCT method. Methods 2001, 25(4):402-408.
27. Cao Y.-Z., Reddy C.C., Sordillo L.M. Altered eicosanoid biosynthesis in selenium-deficient endothelial cells. Free Radic Biol Med 2000, 28(3):381-389.
28. Trigona W.L., Mullarky I.K., Cao Y., Sordillo L.M. Thioredoxin reductase regulates the induction of haem oxygenase-1 expression in aortic endothelial cells. Biochem J 2006, 394(1):207-216.
29. Contreras G.A., Raphael W., Mattmiller S.A., Gandy J., Sordillo L.M. Nonesterified fatty acids modify inflammatory response and eicosanoid biosynthesis in bovine endothelial cells. J Dairy Sci 2012, 95(9):5011-5023.
30. Lee D.M., Kiener H.P., Agarwal S.K., et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007, 315(5814):1006-1010.
31. Vunta H., Belda B.J., Arner R.J., Reddy C.C., Vanden Heuvel J.P., Prabhu K.S. Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res 2008, 52(11):1316-1323.
32. Li A.C., Brown K.K., Silvestre M.J., Willson T.M., Palinski W., Glass C.K. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000, 106(4):523-531.
33. Sordillo L.M., Pighetti G.M., Davis M.R. Enhanced production of bovine tumor necrosis factor-α during the periparturient period. Vet Immunol Immunopathol 1995, 49(3):263-270.
34. Prabhu K.S., Zamamiri-Davis F., Stewart J.B., Thompson J.T., Sordillo L.M., Reddy C.C. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kappaB in up-regulation. Biochem J 2002, 366(1):203-209.
35. Walther M., Holzhutter H.-G., Kuban R.J., Wiesner R., Rathmann J., Kuhn H. The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere. Mol Pharmacol 1999, 56(1):196-203.
36. Simopoulos A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002, 56(8):365-379.
37. Shin K.-M., Shen L., Park S.J., Jeong J.-H., Lee K.-T. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kB inactivation. Journal of Pharmacy and Pharmacology 2009, 61(4):479-486.
38. Shiraki T., Kamiya N., Shiki S., Kodama T.S., Kakizuka A., Jingami H. α,β-Unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor γ. J Biol Chem 2005, 280(14):14145-14153.
39. Patwardhan A.M., Scotland P.E., Akopian A.N., Hargreaves K.M. From the cover: activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci U S A 2009, 106(44):18820-18824.
40. Waddington E.I., Croft K.D., Sienuarine K., Latham B., Puddey I.B. Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. Atherosclerosis 2003, 167(1):111-120.
41. Cheng A.W.M., Stabler T.V., Bolognesi M., Kraus V.B. Selenomethionine inhibits IL-1 beta inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthritis Cartilage 2011, 19(1):118-125.